Back to Search
Start Over
Association of Genetic Variants for Plasma LRG1 With Rapid Decline in Kidney Function in Patients With Type 2 Diabetes.
- Source :
- Journal of Clinical Endocrinology & Metabolism; Aug2021, Vol. 106 Issue 8, p2384-2394, 11p
- Publication Year :
- 2021
-
Abstract
- <bold>Context: </bold>Elevated levels of plasma leucine-rich α-2-glycoprotein 1 (LRG1), a component of transforming growth factor beta signaling, are associated with development and progression of chronic kidney disease in patients with type 2 diabetes (T2D). However, whether this relationship is causal is uncertain.<bold>Objectives: </bold>To identify genetic variants associated with plasma LRG1 levels and determine whether genetically predicted plasma LRG1 contributes to a rapid decline in kidney function (RDKF) in patients with T2D.<bold>Design and Participants: </bold>We performed a genome-wide association study of plasma LRG1 among 3694 T2D individuals [1881 (983 Chinese, 420 Malay, and 478 Indian) discovery from Singapore Study of Macro-angiopathy and Micro-vascular Reactivity in Type 2 Diabetes cohort and 1813 (Chinese) validation from Diabetic Nephropathy cohort]. One- sample Mendelian randomization analysis was performed among 1337 T2D Chinese participants with preserved glomerular filtration function [baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2)]. RDKF was defined as an eGFR decline of 3 mL/min/1.73 m2/year or greater.<bold>Results: </bold>We identified rs4806985 variant near LRG1 locus robustly associated with plasma LRG1 levels (meta P = 6.66 × 10-16). Among 1337 participants, 344 (26%) developed RDKF, and the rs4806985 variant was associated with higher odds of RDKF (meta odds ratio = 1.23, P = 0.030 adjusted for age and sex). Mendelian randomization analysis provided evidence for a potential causal effect of plasma LRG1 on kidney function decline in T2D (P < 0.05).<bold>Conclusion: </bold>We demonstrate that genetically influenced plasma LRG1 increases the risk of RDKF in T2D patients, suggesting plasma LRG1 as a potential treatment target. However, further studies are warranted to elucidate underlying pathways to provide insight into diabetic kidney disease prevention. [ABSTRACT FROM AUTHOR]
- Subjects :
- GENETIC variation
TYPE 2 diabetes
KIDNEY physiology
GENOME-wide association studies
CHRONIC kidney failure
GLOMERULAR filtration rate
DISEASE progression
RESEARCH
GENETICS
KIDNEYS
SEQUENCE analysis
RESEARCH methodology
MEDICAL cooperation
EVALUATION research
COMPARATIVE studies
GLYCOPROTEINS
RESEARCH funding
DIABETIC nephropathies
Subjects
Details
- Language :
- English
- ISSN :
- 0021972X
- Volume :
- 106
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Journal of Clinical Endocrinology & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 151494556
- Full Text :
- https://doi.org/10.1210/clinem/dgab268